All News about Axonics Inc
![](https://mms.businesswire.com/media/20240801925417/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics Reports Second Quarter 2024 Financial Results
August 01, 2024
From Axonics, Inc.
Via Business Wire
![](https://investorplace.com/wp-content/uploads/2020/10/robotics-stocks-ai-1600.jpg)
![](https://mms.businesswire.com/media/20240516138680/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Beyond The Numbers: 7 Analysts Discuss Axonics Stock
February 29, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Analyst Scoreboard: 5 Ratings For Axonics
January 09, 2024
Via Benzinga
![](https://g.foolcdn.com/editorial/images/760594/business-people-shaking-hands.jpg)
![](https://mms.businesswire.com/media/20240430236658/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics Reports First Quarter 2024 Financial Results
April 30, 2024
From Axonics, Inc.
Via Business Wire
![](https://www.marketbeat.com/logos/articles/med_20240430092737_boston-scientific-bucks-the-medtech-slow-down-and.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/04/18/BSX.png?width=1200&height=800&fit=crop)
FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious'
April 18, 2024
Via Benzinga
Exposures
Product Safety
![](https://mms.businesswire.com/media/20240322944795/en/788134/5/Axonics_Logo_-_Color.jpg)
From Axonics, Inc.
Via Business Wire
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://mms.businesswire.com/media/20240314344838/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://mms.businesswire.com/media/20240229918338/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://mms.businesswire.com/media/20240228530784/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
February 28, 2024
From Axonics, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20240227899039/en/1919461/22/Latest_KSF_M%26A.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/BSX.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://www.investors.com/wp-content/uploads/2019/11/Stock-bounce-05-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/11/robinhood_markets_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/10/strong-buy-stocks.jpg)
![](https://ml.globenewswire.com/media/aeea7200-7231-49dd-b4ba-ec680464b28c/small/brodsky-smith-logo-png-png.png)
From Brodsky & Smith LLC
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2019/07/crox1600.jpg)
![](https://investorplace.com/wp-content/uploads/2019/09/deal-handshake.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/08/axnx.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/01/08/image_1.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2023/05/Stock-merckhq-rahway-03-company.jpg)
![](https://mms.businesswire.com/media/20240108495248/en/1567526/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 08, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240108461747/en/788134/5/Axonics_Logo_-_Color.jpg)
From Axonics, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.